The effects of Lu3+, Gd3+ and Ga3+ substitution on the photoluminescence of Y2.95-x-yLuxGdyAlzGa5-zO12:0.05Ce3+ phosphors for high-power white AC-LEDs.

Various yellowish-green persistent phosphors of Y2.95-x-yLuxGdyAl5-zGazO12:0.05Ce3+ (x = 0-1, y = 0-1, z = 1-4) were successfully synthesized by the one-step high-temperature solid-state reaction method in air. The effects of simultaneous doping of Lu3+, Gd3+ and Ga3+ on the luminescence properties of the phosphors were investigated in detail for the first time. Herein, the microstructure, morphology, afterglow performance, luminescence properties, thermoluminescence, thermal quenching and flicker index of the efficient blue-light-activated Y2.95-x-yLuxGdyAl5-zGazO12:0.05Ce3+ phosphors were tested. The τ90 and τ80 values of Y1.45LuGd0.5Al2.5Ga2.5O12:0.05Ce3+ are 10.8 ms and 33.2 ms, respectively. These parameters are important in terms of effectiveness in reducing flicker in alternating current (AC) LEDs. Compared with the conventional Y3Al2Ga3O12:Ce3+ phosphor, the Y1.45LuGd0.5Al2.5Ga2.5O12:0.05Ce3+ phosphor has a better luminescence performance, stronger afterglow performance, and lower flicker index. The quantum yield of the Y1.45LuGd0.5Al2.5Ga2.5O12:0.05Ce3+ phosphor was 86.42% and the luminous efficiency of the LED devices prepared with it reached 92.12 lm W-1 when operated at 100 mA. Integrating sphere and spectroradiometer tests as well as CIE chromaticity diagrams indicate that the AC-WLEDs assembled by mixing the Y1.45LuGd0.5Al2.5Ga2.5O12:0.05Ce3+ phosphor and a commercial red phosphor in an appropriate ratio could obtain ideal white light with a high color-rendering index (87.9) and the flickering index was successfully reduced from 100% to 61.4%.

Function and mechanism of GBP1 in the development and progression of cervical cancer.

Guanylate binding protein 1 (GBP1) is the most concerned member of the GBP family, which has a series of effects such as anti-infection and anti-angiogenesis. Its role in malignant tumors including cervical cancer is still controversial. We aim to explore the effects of GBP1 on cervical cancer through bioinformatics and related experiments. In this study, we first found that GBP1 was generally expressed in cervical cancer in various online databases and was closely related to immune invasion. Secondly, we used multicolor immunofluorescence technology to verify the expression of GBP1 in cervical cancer tissues and its relationship with immune invasion, and explored its relationship with the prognosis of patients with cervical cancer. Knockdown and overexpression assays of GBP1 in vitro were used to prove GBP1 as a potential oncogene of cervical cancer, and its carcinogenicity was verified by in vivo experiment. In order to explore the potential mechanism of GBP1 in promoting cancer, RNA-seq was performed on GBP1 overexpression and knockdown expression cell lines, and GBP1 knockdown and overexpression were found to be associated with many RNA alternative splicing events, suggesting that GBP1 maybe a RNA binding protein (RBP) which affect the biological characteristics of cervical cancer cells through the alternative splicing pathway. However, the later RNA binding protein immunoprecipitation (RIP) assay proved that GBP1 was not a direct alternative splicing factor, while the co-immunoprecipitation (CoIP)-mass spectroscopy (MS) assay combined with protein protein interaction (PPI) analysis proved that 8 alternative splicing factors including Heterogeneous Nuclear Ribonucleoprotein K (HNRNPK) were interacting proteins of GBP1. Combined with the existing reports and the results of RNA-seq alternative splicing analysis, it is speculated that GBP1 may regulate the alternative splicing of CD44 protein by binding to interacting protein-HNRNPK, and thus play a role in promoting cancer in cervical cancer.

Erythropoietin receptor is a risk factor for prognosis: A potential biomarker in lung adenocarcinoma.

Lung cancer has the highest mortality rate of all cancers, and LUAD's survival rate is particularly poor. Erythropoietin receptor (EPOR) can be detected in lung adenocarcinoma (LUAD), however, the expression levels and prognostic value of EPOR in LUAD are still unclear. In our study, clinicopathological data of 92 LUAD patients between January 2008 and June 2016, multiple bioinformatics databases and immunohistochemistry were used to explore the EPOR expression, the mutant genes affecting EPOR expression, and the correlation of EPOR expression with oxidative stress - related genes, prognosis, immune microenvironment. All statistical analyses were performed in the R version 4.1.1. The study found that EPOR expression might be down-regulated at the mRNA levels and significantly up-regulated at the protein levels in LUAD, which indicates that the mRNA and protein levels of EPOR are inconsistent. The muTarget showed that the expression of EPOR was significantly different between the mutant group and the wild group of 15 genes, including DDX60L and C1orf168. Importantly, we found that EPOR was associated with VEGF and HIF family members, and had significant positive correlation with oxidative stress - related genes such as CCS, EPX and TXNRD2. This suggests that EPOR may be involved in the regulation of oxidative stress. The Kaplan-Meier Plotter and PrognoScan databases consistently concluded that EPOR was associated with prognosis in LUAD patients. Our clinicopathological data showed that high EPOR expression was associated with poorer overall survival (29.5 vs 46 months) and had a good predictive ability for 4-year and 5-year survival probability. EPOR is expected to be a potential new prognostic marker for LUAD.

NIR to MIR ultra-broadband supercontinuum laser source based on all-silica fibers.

We demonstrated an ultra-broadband supercontinuum (SC) laser source with a wavelength range spanning the near-infrared (NIR) to mid-infrared (MIR) region. The SC spectrum was generated in a very short piece of highly nonlinear silica fiber (HNLF) which has a zero-dispersion wavelength (ZDW) of 1.55 µm. The pump source used has a spectral coverage of 1.5∼2.4 µm which covers the ZDW of HNLF, resulting in a dramatic blue and red shift of the spectrum through strong non-linear effects. As the pump laser pulse launched into HNLF, a SC spectrum with broadband range of 0.92∼2.92 µm and maximum average power of 5.09 W was achieved, which sets record coverage of HNLF-based watts magnitude SC laser sources for now, to the best of the authors' knowledge. The setup consists of silica fiber that can be considered easy-to-implement and with a cost-effectiveness scheme for ultra-broadband SC generation that could be easily applied to optical fiber sensing and spectral imaging technology.

Near-infrared pumped, octave-tunable, on-chip mid-infrared Raman soliton source.

This article proposes and numerically demonstrates a widely tunable on-chip Raman soliton source based on a cascaded As2Se3 waveguide. The cascaded sub-waveguides (input and output) with varying widths act as nonlinear devices, while a tapered waveguide is arranged between them to achieve low-loss transmission. The input waveguide provides anomalous dispersion in the near-infrared band, thereby enabling the 1.96 µm source for Raman soliton self-frequency shift (SSFS) pumping. The output waveguide exhibits large anomalous dispersion and good mode confinement in the mid-infrared band thus supporting further SSFS process. A 2.29∼4.57 µm tunable Raman source is theoretically realized in this on-chip platform. This work presents a simple and easy-to-implement strategy to extend the tuning range of on-chip sources. Notably, to the best of our knowledge, this is the first demonstration of the cascading strategy for SSFS process in an on-chip platform. The proposed tunable source has great potential in integrated spectroscopy, gas sensing, and LiDAR applications.

Ferroptosis-related genes in cervical cancer as biomarkers for predicting the prognosis of gynecological tumors.

Background: Ferroptosis has been identified as a potent predictor of cancer prognosis. Currently, cervical cancer ranks among the most prevalent malignant tumors in women. Enhancing the prognosis for patients experiencing metastasis or recurrence is of critical importance. Consequently, investigating the potential of ferroptosis-related genes (FRGs) as prognostic biomarkers for cervical cancer patients is essential. Methods: In this study, 52 FRGs were obtained from the GSE9750, GSE7410, GSE63514, and FerrDb databases. Six genes possessing prognostic characteristics were identified: JUN, TSC22D3, SLC11A2, DDIT4, DUOX1, and HELLS. The multivariate Cox regression analysis was employed to establish and validate the prognostic model, while simultaneously performing a correlation analysis of the immune microenvironment. Results: The prediction model was validated using TCGA-CESC and GSE44001 datasets. Furthermore, the prognostic model was validated in endometrial cancer and ovarian serous cystadenocarcinoma cases. KM curves revealed significant differences in OS between high-risk and low-risk groups. ROC curves demonstrated the stability and accuracy of the prognostic model established in this study. Concurrently, the research identified a higher proportion of immune cells in patients within the low-risk group. Additionally, the expression of immune checkpoints (TIGIT, CTLA4, BTLA, CD27, and CD28) was elevated in the low-risk group. Ultimately, 4 FRGs in cervical cancer were corroborated through qRT-PCR. Conclusion: The FRGs prognostic model for cervical cancer not only exhibits robust stability and accuracy in predicting the prognosis of cervical cancer patients but also demonstrates considerable prognostic value in other gynecological tumors.

The ancient CgPEPCK-1, not CgPECK-2, evolved into a multifunctional molecule as an intracellular enzyme and extracellular PRR.

Phosphoenolpyruvate carboxykinase (PEPCK) is a well-known lyase involved in gluconeogenesis, while their evolution and function differentiation have not been fully understood. In this study, by constructing a phylogenetic tree to examine PEPCKs throughout the evolution from poriferans to vertebrates, Mollusk was highlighted as the only phylum to exhibit two distinct lineages, Mollusca_PEPCK-1 and Mollusca_PEPCK-2. Further study of two representative members from Crassostrea gigas (CgPEPCK-1 and CgPEPCK-2) showed that they both shared conserved sequences and structural characteristics of the catalytic enzyme, while CgPEPCK-2 displayed a higher expression level than CgPEPCK-1 in all tested tissues, and CgPEPCK-1 was specifically implicated in the immune defense against LPS stimulation and Vibrio splendidus infection. Functional analysis revealed that CgPEPCK-2 had stronger enzymatic activity than CgPEPCK-1, while CgPEPCK-1 exhibited stronger binding activity with various PAMPs, and only the protein of CgPEPCK-1 increased significantly in hemolymph during immune stimulation. All results supported that distinct sequence and function differentiations of the PEPCK gene family should have occurred since Mollusk. The more advanced evolutionary branch Mollusca_PEPCK-2 should preserve its essential function as a catalytic enzyme to be more specialized and efficient, while the ancient branch Mollusca_PEPCK-1 probably contained some members, such as CgPEPCK-1, that should be integrated into the immune system as an extracellular immune recognition receptor.

Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors.

Background: Erythropoietin receptor (EPOR), a member of the cytokine class I receptor family, mediates erythropoietin (EPO)-induced erythroblast proliferation and differentiation, but its significance goes beyond that. The expression and prognosis of EPOR in cancer remain unclear. Methods: This study intended to perform a pan-cancer analysis of EPOR by bioinformatics methods. Several databases such as GTEx, TCGA, CCLE, and others were used to explore the overall situation of EPOR expression, and the correlation of EPOR expression with prognosis, microRNAs (miRNAs), immune infiltration, tumor microenvironment, immune checkpoint genes, chemokines, tumor mutation burden (TMB), microsatellite instability (MSI), methyltransferases, and DNA mismatch repair (MMR) genes in 33 tumors was analyzed. In addition, we compared the promoter methylation levels of EPOR in cancer tissues with those in normal tissues and performed protein-protein interaction network, gene-disease network, and genetic alteration analyses of EPOR, and finally enrichment analysis of EPOR-interacting proteins, co-expressed genes, and differentially expressed genes. Results: The TCGA database showed that EPOR expression was upregulated in BLCA, CHOL, HNSC, KIRC, LIHC, STAD, and THCA and downregulated in LUAD and LUSC. After combining the GTEx database, EPOR expression was found to be downregulated in 18 cancer tissues and upregulated in 6 cancer tissues. The CCLE database showed that EPOR expression was highest in LAML cell lines and lowest in HNSC cell lines. Survival analysis showed that high EPOR expression was positively correlated with OS in LUAD and PAAD and negatively correlated with OS in COAD, KIRC, and MESO. Moreover, EPOR had a good prognostic ability for COAD, LUAD, MESO, and PAAD and also influenced progression-free survival, disease-specific survival, disease-free survival, and progression-free interval in specific tumors. Further, EPOR was found to play a non-negligible role in tumor immunity, and a correlation of EPOR with miRNAs, TMB, MSI, and MMR genes and methyltransferases was confirmed to some extent. In addition, the enrichment analysis revealed that EPOR is involved in multiple cancer-related pathways. Conclusion: The general situation of EPOR expression in cancer provided a valuable clinical reference. EPOR may be target gene of hsa-miR-575, etc. A pan-cancer analysis of panoramic schema revealed that EPOR not only may play an important role in mediating EPO-induced erythroblast proliferation and differentiation but also has potential value in tumor immunity and is expected to be a prognostic marker for specific cancers.

Highly sensitive strain sensor based on a long-period fiber grating with chain-shaped structure.

In this paper, a novel chain-shaped long-period fiber grating (CS-LPFG) for strain measurement is investigated and experimentally demonstrated. This structure is achieved by polishing periodic slant planes on a single-mode fiber with a high-frequency CO2 laser. The chain-shaped structures improved the strain sensitivity of the sensor while shortening the length of the sensing unit. Experimental results show that the strain sensitivity of CS-LPFG is 34.8 pm/µÎµ in the range of 0-650 µÎµ, and the total length of the sensing unit is significantly reduced to 7.5 mm. Meanwhile, the temperature-strain cross talk is 1.6 µÎµ/°C, which is much lower than that of most fiber strain sensors.

Compact fiber strain sensor fabricated by a CO2 laser.

In this Letter, a novel, to the best of our knowledge, parallel inclined planes long period fiber grating (PIP-LPFG) for strain measurement is proposed. This structure is fabricated by a high frequency CO2 laser, which has polished periodic parallel inclined planes on a single mode fiber (SMF). Refractive index modulation (RIM) over a large area on the surface of the SMF significantly shortens the total length of the grating, and the structure of parallel inclined planes efficiently enhance the strain sensitivity of PIP-LPFG. Experimental results show that this LPFG with a miniature length of 3.9 mm has a good repeatability and stability of strain response, which can reach to 116 pm/µÎµ in the dynamic range of 0-425 µÎµ. Meanwhile, the temperature sensitivity of PIP-LPFG is 54.7 pm/°C in the dynamic range of 30-170°C.